Caraway’s therapeutic approach leverages genetic data and unique biological understanding to develop proprietary small molecules that activate cellular clearance and recycling processes – accelerating clearance of accumulated toxic materials and defective cellular components. 

Biotechnology

Caraway Therapeutics

Martin Williams

Sean Blake

Jayhong Chong

Magdalene Moran

Rhonda M. Chicko

Jeff Packman

The Scientific Advisors at Caraway Therapeutics play a crucial role in guiding the company’s research and development strategy by providing expert insights on genetic data and biological processes. They leverage their expertise to inform the design of proprietary small molecules, ensuring that the therapeutic approach effectively accelerates the clearance of toxic materials and enhances cellular function. Collectively, they contribute to advancing innovative solutions in the field of cellular health and therapeutic development.

Scientific Advisors

Leadership Team

Research and Development

Scientific Advisors

About

Team members

Other teams at Caraway Therapeutics

Leadership Team

Research and Development